Browse by Tags

India Leads the Way with Generic Drugs But As a Sad Side Effect They are Also Leading the Way With Illegal Counterfeit Drugs

It’s the same old story with counterfeits, whether it is in India or here in the US, they are everywhere and with the global economic structure we have today, counterfeits travel everywhere too, just like the real drugs. We see this ads on the internet...

Published Sun, Sep 09 2010 4:16 PM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, drugs, healthcare, tags, Pharma, Generic Drugs, Antibiotics, India, labels, US, Bar Codes, counterfeit drugs

Merck Loses Patent Protection Battle with Zetia Cholesterol Drug – Intellectual Property Cases Continue

The legal battles continue in court over drug patents and the big question today as to what is in a drug patent keeps arising. With the focus today on getting affordable and generic medications to market, patents are being challenged all over. ...

Published Thu, Apr 04 2010 1:13 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Pills, Generic Drugs, Merck, Court, Schering-Plough, legal battles, Glenmark

Teva Pharmaceutical Has Approval to Begin Marketing Generics for 2 Merck Hypertension Drugs – Hyzaar and Cozaar

This is interesting and a deal was made here so Teva has a 180 day exclusive. On one hand we have Teva in court with Merck over Singulair and on the other hand here, they get a deal. Teva is probably the most aggressive pharma company today...

Published Wed, Apr 04 2010 11:50 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Hypertension, Generic Drugs, Merck, Patents, Teva, Intellutual property, Cozaar, Hyzaar

Teva Wins Again – Merck’s Patent on Temodar Chemotherapy Drug Not Enforceable

A disappointment for Merck and this is not the only patent tied up in the legal system today, Singulair is another one where the patent is being questioned. Merck plans to appeal the case according to the article, ho hum, more legal cases to drive...

Published Tue, Jan 01 2010 3:05 PM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Pharma, FDA, Generic Drugs, Merck, Patents, Amgen, Intellectual property, Teva, legal cases

Generic Prevacid SoluTab Is Here – Teva Wins Court Battle on Patent Challenge For Heartburn Drug

How long is a drug patent going to last? This is a big question here today with Teva and Mylan being able to start marketing the generic version tomorrow. For us the patients, another big saver in the pharma area if you take Prevacid. ...

Published Tue, Nov 11 2009 9:04 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Generic Drugs, Intellectual property, Teva, Takeda, Mylan, patent, Prevacid

Lilly Sells Manufacturing Plant in Indiana to German Chemical Company

The good news though is that it appears employees will be offered jobs with the new owner. The sale is perhaps an omen to how some of big pharma is getting ready for additional generic drug competition. BD BOSTON, Oct 14 (Reuters) -...

Published Thu, Oct 10 2009 11:52 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Generic Drugs, Lilly, acquisitions, Evonik

Media in the News About Dangers of Generic Drugs – Survey Says it Disturbs and Could Influence Us

It appears just as pharma advertisements work to promote name brands, media with warnings about dangerous generic drugs appear to have a similar effect. What is interesting in this survey is the most popular emotion shown is “disturbed”, so are...

Published Fri, Sep 09 2009 8:01 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, healthcare, Pharma, Generic Drugs, Marketing, Media, healthcare reform, surveys

Silverlink – An Automated HealthCare Notification Communication System

Communications in healthcare get a bit smarter and this company provides the automated telephone notification services we either like or dislike, depending on what you are being notified about. You can read through further and see some of the “smart...

Published Tue, Jul 07 2009 12:21 PM by The Medical Quack

Filed under: Medically Related, Technology, healthcare, Pharma, Generic Drugs, Recalls, communication, Web 2.0, Silverlink

Walmart Employee Health Benefit Plan – Half of the Name Brands Covered Will Be A Thing of the Past

When it comes to saving a buck, WalMart is king and for those employees who can afford their health insurance plan, there will be far less name brand drugs to choose from, so even for employees, the $4.00 generic is the suggested answer. You can...

Published Mon, Jul 07 2009 11:49 PM by The Medical Quack

Filed under: Medically Related, Insurance, Pharma/FDA News, healthcare, health insurance, Pharma, Prescriptions, Generic Drugs, Patents, Walmart, name brand drugs, $4.00 drugs

What’s in a Drug Patent for Pfizer – There are several Court Cases are Challenging Others Too

The latest battle is with Pfizer and Mylan, a generic drug manufacturer going to court. Mylan is ready to go to market but not until Pfizer gives the go ahead and that date is in the year 2017. Pfizer is not the only one being challenged by...

Published Tue, Jun 06 2009 2:58 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Generic Drugs, Merck, Pfizer, Patents, Biosimilars, Teva, intilectual property, court case, follow me drugs, Mylan

Are Generic Drug entries into the market being delayed? What’s in a Patent?

With our new administration, this is getting to be real heated topic and everyone has their points. Right now with some medications not having a generic equivalent, patents are being challenged to bring a generic to market sooner. One of the...

Published Sun, Mar 03 2009 2:59 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Genomics, healthcare, Pharma, Generic Drugs, warfarin, NIH, Lawsuits, blood thinners, Plavix, Bristol-Myer Squibb

US Drug Sales are Flat – India Experiencing a 13.3% growth

A comparison to the growth in the pharmaceutical business, we are basically flat here, while overseas in India the market continues on a steady growth pattern. Also, in the US it is becoming much more difficult for sales and marketing representatives...

Published Thu, Mar 03 2009 3:53 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, healthcare, Pharma, Generic Drugs, India, Drug Sales, United States

Pfizer Inks Deal to Sell More Generics – From Aurobindo Pharma in India

39 Generic Drugs to be sold in the US, and 12 injectable drugs are part of the deal. Pfizer is not alone, other pharma companies are doing the same as drug patents are getting closer to expiring. In the meantime, we have this inquiry going...

Published Wed, Mar 03 2009 2:50 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Biotech, Generic Drugs, Pharmaceuticals, Pfizer, China, India, Investing, Harvard Medical Center

Merck and Teva Go to Court over Singulair Going Generic

Teva has been pretty aggressive of late. Both Merck and Teva are also preeminent players in pharma's race to develop Biosimilar drugs. Patents and intellectual property are big news today and even with just the challenge, Teva might stand...

Published Wed, Feb 02 2009 5:11 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, healthcare, Pharma, Generic Drugs, Merck, Patents, Teva, Singulair

Syndication

Recent Posts

Tags

Archives